Skin and Connective Tissue Diseases

445 trials 165 recruiting

Filter these 445 trials by phase, country and sponsor.

Open in Search →

A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis Ended

2022-502888-38-00 Atopic dermatitis 4 2023-09-25
A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis Ended

2022-501476-25-00 Atopic Dermatitis Eczema 5 2023-09-12
A study to understand how well DC806 works and how safe it is in participants with plaque psoriasis Ended

2022-502249-90-00 Plaque Psoriasis 4 2023-08-31
To access the effect of SCD-044 in treatment of moderate to severe atopic dermatitis Ended

2024-511615-16-00 atopic dermatitis 4 2023-08-25
A PHASE 1 STUDY TO ASSESS THE EXCRETION BALANCE, PHARMACOKINETICS, AND METABOLISM OF [14C] DC 806 IN HEALTHY MALE PARTICIPANTS. Ended

2023-505367-36-00 Healthy 3 2023-08-24
An early-stage clinical study of a potential new medicine for patients with Netherton Syndrome Ended

2022-502853-32-00 Netherton's Syndrome 9 2023-08-18
A phase-2, multi-centre, prospective, randomized, standard-of-care plus placebo-controlled, patient and central evaluator blinded, parallel … Ended

2022-502048-10-00 diabetic foot ulcers 4 2023-07-21
Treatment of Keratolytic Winter Erythema in adults with systemic nitroxoline Ended

2022-501726-38-00 Keratolytic Winter Erythema 4 2023-06-30
A Phase 3 Study Investigating the Efficacy, Safety, and Tolerability of Ritlecitinib in Participants with Nonsegmental Vitiligo Ended

2022-501668-16-00 NON SEGMENTAL VITILIGO 5 2023-06-26
A multicenter, randomized, double-blind, parallel, three-arm, active- and placebo-controlled therapeutic equivalence for the comparison of c… Ended

2024-518430-91-00 Acne Vulgaris 5 2023-06-13
A study to test whether spesolimab helps people with skin disease called Netherton syndrome Ended

2022-501104-10-00 Netherton syndrome (NS) 10 2023-06-06
A 2-year Open-label Extension Study to Assess the Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Patients with Modera… Ended

2022-502575-30-00 Atopic Dermatitis 5 2023-05-23
Study of M5049 in DM and PM Participants (NEPTUNIA) Ended

2022-501351-82-00 Dermatomyositis, Polymyositis 4 2023-05-23
A Multicenter, Open-Label, Evaluator-Blinded, Randomized Study to Evaluate the Safety and Tolerability of Single-Dose IV Oritavancin for the… Ended

2024-516385-10-00 Acute Bacterial Skin and Skin Structure Infections 4 2023-05-02
This is a phase 2, randomized, double blind, multicenter study evaluating the efficacy and safety of the combination of methotrexate plus UV… Ended

2024-512766-34-00 Vitiligo with new lesions or extension of old lesions d 4 2023-04-28
A Phase 1 Study Evaluating Relative Bioavailability of Sprinkled Ritlecitinib in Applesauce, Yoghurt, and Strawberry Jam and Evaluating the … Ended

2022-502872-22-00 Alopecia Areata, Rheumatoid Arthritis, Vitiligo, Ulcera 3 2023-04-28
Study to Evaluate the Efficacy, Pharmacokinetics, Safety, and Immunogenicity of Subcutaneously Administered Ustekinumab or Guselkumab in Ped… Ended

2023-507144-36-00 Juvenile psoriatic arthritis 5 2023-04-20
An efficacy and safety study of HRO350 in patients with mild-to-moderate psoriasis (the ‘HeROPA’ study) Ended

2022-501850-12-00 Psoriasis 4 2023-03-15
Safety, tolerability, pharmacokinetics, and pharmacodynamics of intravenous and subcutaneous multiple rising doses of BI 765250 versus place… Ended

2024-512420-10-00 Plaque psoriasis 3 2023-03-09
A Parallel-group (2-Arm), Randomized, Double-blind, 12-week Trial to Evaluate the Efficacy and Safety of MC2-25 Cream and MC2-25 Vehicle in… Ended

2022-500044-38-01 Chronic Kidney Disease associated Pruritus 4 2023-02-20
Moisturiser effect on atopic dermatitis relapse prevention in children Ended

2022-501184-41-00 atopic dermatitis/eczema 6 2023-02-13
Evaluation of the value of perianal infiltration during thermodestruction of hemorrhoidal disease by Radiofrequency (RAFAELO® procedure) Ended

2024-514117-35-00 hemorrhoidal disease 11 2023-01-10
Treatment with Xeljanz in a population of patients with cutaneous T cell lymphoma Ended

2022-500599-79-00 Mycosis Fungoides 4 2023-01-10
Effect of mesenchymal stem cells on healing of foot ulcers in diabetes patients. A phase I pilot study. Ended

2023-505961-10-00 Diabetic foot ulcus 9 2022-12-15